Laurence Kandel v. Urological Treatment and Research , Ralph Benson, Dean Knoll & Institute for Urological Research

CourtCourt of Appeals of Tennessee
DecidedJuly 10, 2001
DocketM2000-02128-COA-R3-CV
StatusPublished

This text of Laurence Kandel v. Urological Treatment and Research , Ralph Benson, Dean Knoll & Institute for Urological Research (Laurence Kandel v. Urological Treatment and Research , Ralph Benson, Dean Knoll & Institute for Urological Research) is published on Counsel Stack Legal Research, covering Court of Appeals of Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laurence Kandel v. Urological Treatment and Research , Ralph Benson, Dean Knoll & Institute for Urological Research, (Tenn. Ct. App. 2001).

Opinion

IN THE COURT OF APPEALS OF TENNESSEE AT NASHVILLE July 10, 2001 Session

LAURENCE B. KANDEL, M.D. v. THE CENTER FOR UROLOGICAL TREATMENT AND RESEARCH, P.C., RALPH C. BENSON, JR., M.D., L. DEAN KNOLL, M.D., and THE INSTITUTE FOR UROLOGICAL RESEARCH

An Appeal from the Circuit Court for Davidson County No. 98C-1987 Barbara N. Haynes, Judge

No. M2000-02128-COA-R3-CV - Filed April 17, 2002

This is a breach of contract case. The plaintiff physician entered into an employment contract with the defendant physician’s group. The contract provided that the physician would work for the group for one year, and that the parties would then “negotiate in good faith” to give the employee physician the opportunity to purchase stock in the group. At the end of the physician’s first year of employment, the parties negotiated, but reached an impasse. Subsequently, negotiations ceased, and the physician’s employment was terminated. He filed suit against the group, alleging that the defendants breached the contract to “negotiate in good faith,” and that the defendants committed promissory fraud in inducing him into signing the employment agreement. The trial court granted summary judgment in favor of the defendants on both counts. The physician now appeals. We affirm. Even if Tennessee recognizes a cause of action for breach of an agreement to negotiate in good faith, the evidence does not demonstrate such a breach, and does not establish promissory fraud. Tenn. R. App. P. 3 Appeal as of Right; Judgment of the Circuit Court is Affirmed.

HOLLY K. LILLARD, J., delivered the opinion of the court, in which W. FRANK CRAWFORD , P.J., and DAVID R. FARMER , J., joined.

Alfred H. Knight and William R. Willis, Willis & Knight, Nashville, Tennessee, for the appellant Laurence B. Kandel, M.D.

R. Dale Grimes, Bryan E. Larson, and Andrea Taylor McKellar, Bass, Berry & Sims, Nashville, Tennessee, for the appellees The Center for Urological Treatment and Research, P.C., Ralph C. Benson, Jr., M.D., L. Dean Knoll, M.D., and The Institute for Urological Research. OPINION

This is a breach of contract case. In the spring of 1996, plaintiff/appellant Laurence B. Kandel, M.D. (“Dr. Kandel”), was engaged in the academic practice of urology in the state of New York. During that time, Dr. Kandel entered into negotiations with defendant/appellee Ralph Benson, M.D. (“Dr. Benson”), and defendant/appellee Dean Knoll, M.D. (“Dr. Knoll”), the sole shareholders in Defendant/Appellee The Center for Urological Treatment and Research, P.C. (“CUTR”), regarding Dr. Kandel joining CUTR as an employee in the practice of urology.

In July 1996, the parties executed a contract, effective as of September 15, 1996. The contract contained the following provision:

10. Agreement to Negotiate in Good Faith Toward Purchase of Equity Ownership. The Employer agrees that in the event Employee remains continuously employed by Employer for a period of one (1) year and has achieved Board Certification through the American Board of Urology, Employer will negotiate in good faith with Employee to allow Employee to purchase from Employer that number of shares of Employer’s stock which will permit Employee to own the same number of shares as the stockholder holding the most shares of Employer’s stock at that time. Employer anticipates that the purchase price of such stock shall be based on the GAAP book value of the Employer as of the date of the purchase.

(Emphasis added). Thus, the contract contained a provision requiring the parties to “negotiate in good faith” the sale to Dr. Kandel of an equal ownership share in CUTR at the expiration of one year.

Dr. Kandel remained Board certified, as required under his agreement, and completed his first year of practice at CUTR. Toward the end of his first year, Dr. Kandel raised to Drs. Benson and Knoll the issue of becoming a partner in CUTR pursuant to the terms of the contract. Dr. Kandel alleges that Drs. Benson and Knoll initially told him that he would have to wait another year before he became eligible to buy into the practice. When Dr. Kandel insisted that he had a contractual right to enter into good faith negotiations for the purchase of CUTR stock, the parties began to negotiate Dr. Kandel’s buy-in.

Beginning in September 1997, CUTR made the first of several offers to Dr. Kandel. The parties agreed on many terms of the buy-in, such as the formula to be used in determining the amount of Dr. Kandel’s compensation, the formula to be used to calculate the amount of Dr. Kandel’s buy-in, and the terms of the covenant not to compete. Regarding the amount of Dr. Kandel’s buy-in, the parties contemplated that Dr. Kandel would buy his stock for an amount equal to one-third of the group’s net asset value (assets less liabilities). This would total approximately $141,000, based on a valuation of the group that included over $500,000 in accounts receivable. The parties disagreed, however, on the method for calculating the stock redemption value. CUTR

-2- proposed that, upon termination of Dr. Kandel’s employment, he would sell his stock to CUTR for its book value “provided that no value shall be assigned to accounts receivable.” At the time of the negotiations, eliminating accounts receivable from the equation would have caused the book value of the stock to drop to an amount below zero. However, under CUTR’s proposal, if Dr. Kandel were terminated he would have been entitled to a “severance pay” in an amount equal to 90% of the accounts receivable attributable to the services rendered by Dr. Kandel.

Dr. Kandel refused CUTR’s proposal, asserting that it was not made in good faith because it required him to pay $141,000 for stock that would be essentially worthless if he were required to immediately redeem it. In response, CUTR defended its proposal to Dr. Kandel as it related to the stock redemption terms. In a letter to Dr. Kandel’s attorney dated November 12, 1997, counsel for CUTR explained:

[I]t is [ ] true that Dr. Kandel could be fired the day after he buys into CUTR. However, Dr. Benson’s and Dr. Knoll’s executed Employment and Redemption Agreements also contain similar “without cause” termination provisions that allow CUTR to terminate their employment without cause at any time without requirement of prior notice.

* * *

However, [you] erroneously assume[ ] that Dr. Kandel would receive $0 if his employment with CUTR was terminated the day after he completed his buy-in or at any other time. To the contrary, Dr. Kandel would potentially receive two payments. First, Dr. Kandel, if terminated, is entitled to receive 90% of his accounts receivable . . . . This payment would result in a large payment to Dr. Kandel. Specifically, since Dr. Kandel’s accounts receivable at the end of October approximated $93,000, Dr. Kandel would be entitled to a payment of approximately $84,000. It is important to note, however, that Dr. Kandel’s current accounts receivable are significantly deflated solely because he took a considerable amount of time off during September. A more representative example may be Dr. Benson’s accounts receivable as of October 31, 1997, which approximated $152,000. Under a similar provision in Dr. Benson’s Employment and Redemption Agreement, Dr. Benson, if terminated, would be entitled to a payment of approximately $137,000, or 90% of his accounts receivable.

Even though this payment may not equal or surpass Dr. Kandel’s buy-in amount, it represents a fair price of admission to an established and highly regarded medical practice. It is also important to note that Dr. Kandel is not being asked to pay any amount for goodwill or name, which direct benefit he will receive immediately upon becoming a shareholder without any direct cost to him.

(Footnote omitted).

-3- In a letter dated November 26, 1997, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Engenius Entertainment, Inc. v. Herenton
971 S.W.2d 12 (Court of Appeals of Tennessee, 1997)
Mohrenweiser v. Blomer
573 N.W.2d 704 (Court of Appeals of Minnesota, 1998)
Covington v. Robinson
723 S.W.2d 643 (Court of Appeals of Tennessee, 1986)
Bruce v. Bruce
801 S.W.2d 102 (Court of Appeals of Tennessee, 1990)
Threadgill v. Threadgill
740 S.W.2d 419 (Court of Appeals of Tennessee, 1987)
Jenks v. Jenks
385 S.W.2d 370 (Missouri Court of Appeals, 1964)
Fowler v. Happy Goodman Family
575 S.W.2d 496 (Tennessee Supreme Court, 1978)
Brungard v. Caprice Records, Inc.
608 S.W.2d 585 (Court of Appeals of Tennessee, 1980)
Bain v. Wells
936 S.W.2d 618 (Tennessee Supreme Court, 1997)
Warren v. Estate of Kirk
954 S.W.2d 722 (Tennessee Supreme Court, 1997)
Farmers & Merchants Bank v. Petty
664 S.W.2d 77 (Court of Appeals of Tennessee, 1983)
Venture Associates Corp. v. Zenith Data Systems Corp.
887 F. Supp. 1014 (N.D. Illinois, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Laurence Kandel v. Urological Treatment and Research , Ralph Benson, Dean Knoll & Institute for Urological Research, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laurence-kandel-v-urological-treatment-and-research-ralph-benson-dean-tennctapp-2001.